Understanding Clinical Trials for Prostate Cancer | Treatment Options, Survivorship & Emerging Therapies
Clinical trials can play an important role in prostate cancer treatment by giving patients access to emerging therapies, innovative research, and expanded care options. In this Managing Survivorship discussion, experts explore how clinical trials support prostate cancer patients and families navigating difficult treatment decisions.
Kimberly Allman, MSN, CNP, Medical Director at Telix Pharmaceuticals joins Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education at Prostate Health Education Network, for an informative conversation about clinical trial participation, patient safety, informed consent, reimbursement support, and the future of prostate cancer care.
Key Topics Covered
- How clinical trials expand prostate cancer treatment options
- Access to promising new therapies and emerging treatments
- Common myths and misconceptions about clinical trial safety
- How clinical trials assess potential treatments that may help stop cancer from progressing
- Understanding informed consent and patient protections
- Reimbursement and financial support related to participation
- How to use PHEN’s Find Your Trial (FYT) tool
- Insights into the Merck Omaha-003, Omaha-004, and AstraZeneca EvoPAR-PR02 clinical trials
Clinical trial participation is a personal decision, but understanding available options may help patients and families make more informed decisions about treatment, survivorship, and future care.
Learn more about prostate cancer clinical trials and survivorship resources at PHENTrials.com
